Pfizer gets $2.15 billion settlement
Pfizer's Kindler KO'd by Teva's Yanai
Recon: FDA clears Pfizer booster for 12- to 15-year-olds; Teva found liable in New York opioid trial | RAPS
Manufacturing alerts and issues at Teva, Pfizer, and more
Teva Pharmaceuticals - Wikipedia
Bad news for Momenta and Pfizer is a blessing for Teva
Mylan-Pfizer off-patent merger boosts Teva - Globes
Pfizer's legendary Viagra finally set to face cheaper competition in U.S. | Fierce Pharma
Pfizer, AstraZeneca, Merck, and Teva win tender for new Israeli Innovation Lab | Ctech
Pfizer and Regeneron led pharma's sales growth in Q4 while Teva, Biogen and Gilead lagged | Fierce Pharma
Pfizer and Teva Enter into Settlement Agreement in Patent Dispute Over Xeljanz - IP News Shots
Pfizer reaches $2 billion Protonix settlement with Teva and Sun Pharma - The Economic Times
Pfizer Wins Lyrica Patent Infringement Case Against Teva and Other Generic Drug Manufacturers | American University Intellectual Property Brief
Pfizer is releasing a generic Viagra as its patent expires — Quartz
Israel sharing COVID-19 data with Pfizer to help fine-tune vaccine rollout | Reuters.com
Pfizer, Teva reach deal to allow generic Viagra-World News , Firstpost
Teva Shares Up on Mylan-Pfizer Merger - Hamodia.com
Manufacturing alerts and issues at Teva, Pfizer, and more
Pfizer to settle Xeljanz suit with Teva
Innovation lab driven by AI formed by AstraZeneca, Merck, Pfizer and Teva
US states sue generic firms over 'inflated' prices - PMLiVE
Teva Takes Pfizer and BMS to Court Over Blood Thinner UK Patents - IP News Shots
Pfizer scrambles to fill void after Teva stops making chemo drug often given to children | Fierce Pharma
Israeli study finds major drop in symptomatic COVID-19 cases with Pfizer vaccine | CBC News
Teva to produce coronavirus drug under Pfizer patent – The Observatorial
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Teva to enter Lipitor generic market - Pharmaceutical Technology
Pfizer sues Teva over arthritis treatment
